Drug intelligence / Profile preview

MWX203 S5

Development stage
Unknown
Lead developer
Shanghai Minwei Biotechnology
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Subcutaneous
01

Overview

MWX203 (also written as MWX-203) is an investigational small interfering RNA (siRNA) therapeutic developed by Shanghai Minwei Biotechnology, a subsidiary of Lepu Medical Technology. It is designed to target angiopoietin-like 3 (ANGPTL3) for the treatment of dyslipidemia, mixed dyslipidemia, and hyperlipidemia. By utilizing RNA interference (RNAi) to inhibit the expression of ANGPTL3, MWX203 aims to lower blood lipid levels, including triglycerides and low-density lipoprotein cholesterol (LDL-C). The drug is administered via subcutaneous injection and is currently in Phase 2 clinical development.

02

Targets

ANGPTL3 (Angiopoietin-like protein 3)ASGPR (Asialoglycoprotein Receptor 1)

Beyond the preview

Go deeper on MWX203 S5.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MWX203 S5.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call